Determining the nature of interactions between EGFR and PDGFRA amplified sub-populations in GBMs is a complex biological problem, with factors relating to selection advantages and the phylogeny of these tumours influencing the balance of populations we see in a tumour, as we have demonstrated with our in silico investigation in this paper. The gene discussed is EGFR; the disease is neoplasm.